XtalPi
Min Xu is currently serving as the R&D Manager & Senior Scientist at XtalPi Inc. Prior to joining XtalPi, Min worked as a Postdoctoral Researcher at Yale University and The National Institute on Drug Abuse (NIDA). Min's research projects focused on studying the structural and ligand profiling of the Sigma 1 receptor and the proton gating and selectivity of the TMBIM channel using molecular dynamics simulations. Min holds a Ph.D. in Drug discovery, molecular modelling, and simulations from the University of Zurich.
This person is not in any offices
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.